Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,277 publicly listed stocks with a combined market cap of $1.95 Trillion. XTL Biopharmaceuticals Ltd leads the sector with a market cap of $1.19 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.95 Trillion
Companies Listed
1,277
Largest Company
XTL Biopharmaceuticals Ltd
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1201 |
XTL Biopharmaceuticals Ltd
F:H2K2 |
$1.19 Million | €1.02 Million | Germany | €2.28 | +23.24% | +408.93% | 47.11K |
| 1202 |
Magle Chemoswed Holding Ab
ST:MAGLE |
$1.13 Million | Skr10.53 Million | Sweden | Skr0.51 | +0.99% | -50.00% | 1.02 Million |
| 1203 |
Universal Ibogaine Inc
V:IBO |
$1.13 Million | CA$1.56 Million | Canada | CA$0.01 | +0.00% | +0.00% | 0.00 |
| 1204 |
PHAXIAM Therapeutics S.A.
PA:PHXM |
$1.01 Million | €863.96K | France | €0.10 | +0.00% | +0.00% | 0.00 |
| 1205 |
Integragen
PA:ALINT |
$1.00 Million | €857.95K | France | €0.19 | -4.62% | +37.27% | 601.92K |
| 1206 |
VivoSim Labs, Inc.
NASDAQ:VIVS |
$997.45K | $997.45K | USA | $0.34 | -10.73% | -23.42% | 213.81 Million |
| 1207 |
Biora Therapeutics Inc
NASDAQ:BIOR |
$994.99K | $994.99K | USA | $0.22 | +0.00% | +0.00% | 0.00 |
| 1208 |
4BASEBIO UK SOCIETAS
LSE:4BB |
$989.13K | GBX8.13 Billion | UK | GBX525.00 | +0.00% | +0.00% | 5.37K |
| 1209 |
Valion Bio Inc
NASDAQ:VBIO |
$973.12K | $973.12K | USA | $0.31 | +11.51% | +8.39% | 18.03 Million |
| 1210 |
BIOCURE TECHNOLOGY INC.
F:1WH |
$960.84K | €821.86K | Germany | €0.03 | +21.43% | +34.21% | 0.00 |
| 1211 |
Bioventix
LSE:BVXP |
$959.93K | GBX7.89 Billion | UK | GBX1510.00 | +0.00% | +0.67% | 256.11K |
| 1212 |
Onconetix Inc
NASDAQ:ONCO |
$947.78K | $947.78K | USA | $0.83 | +5.12% | +4.70% | 10.99 Million |
| 1213 |
Kezar Life Sciences Inc
NASDAQ:KZR |
$923.46K | $923.46K | USA | $0.13 | +0.00% | -7.41% | 9.29 Million |
| 1214 |
Geneuro SA
PA:GNRO |
$911.56K | €779.71K | France | €0.03 | +0.00% | +0.00% | 0.00 |
| 1215 |
Ovoca Gold PLC
IR:OVXA |
$856.42K | €732.54K | Ireland | €0.01 | +0.00% | +0.00% | 0.00 |
| 1216 |
Biodexa Pharmaceticals
NASDAQ:BDRX |
$855.77K | $855.77K | USA | $1.32 | -10.81% | -21.43% | 4.45 Million |
| 1217 |
Lyra Therapeutics Inc
NASDAQ:LYRA |
$843.07K | $843.07K | USA | $0.48 | +0.00% | -16.65% | 242.25K |
| 1218 |
Ondine Biomedical Inc
LSE:OBI |
$837.59K | GBX6.88 Billion | UK | GBX13.25 | -3.64% | -3.64% | 8.05 Million |
| 1219 |
ZyVersa Therapeutics Inc.
NASDAQ:ZVSA |
$817.69K | $817.69K | USA | $0.10 | -3.81% | -14.41% | 532.78K |
| 1220 |
Enveric Biosciences Inc
NASDAQ:ENVB |
$813.73K | $813.73K | USA | $1.57 | +9.79% | +18.94% | 2.63 Million |
| 1221 |
Biomotion Sciences Ordinary Shares
NASDAQ:SLXN |
$787.71K | $787.71K | USA | $1.88 | +2.17% | -21.01% | 1.64 Million |
| 1222 |
ALGERNON PHARMACEUT. A
F:AGW0 |
$740.91K | €633.74K | Germany | €0.02 | -2.63% | -43.94% | 9.24K |
| 1223 |
Diagonal Bio AB
ST:DIABIO |
$703.53K | Skr6.54 Million | Sweden | Skr0.00 | +0.00% | -20.00% | 262.11 Million |
| 1224 |
IO Biotech Inc
NASDAQ:IOBT |
$611.57K | $611.57K | USA | $0.01 | +3.66% | +150.00% | 11.67 Million |
| 1225 |
Faron Pharmaceuticals Oy
LSE:FARN |
$582.06K | GBX4.78 Billion | UK | GBX42.00 | +0.00% | +2.44% | 1.76 Million |
| 1226 |
PROMIS NEUROSCIENCES
F:23J0 |
$576.86K | €493.42K | Germany | €6.90 | +2.99% | +1849.15% | 243.66K |
| 1227 |
Poolbeg Pharma PLC
LSE:POLB |
$574.80K | GBX4.72 Billion | UK | GBX6.70 | +4.69% | +8.94% | 58.67 Million |
| 1228 |
BRAXIA SCIENTIFIC CORP.
F:4960 |
$566.56K | €484.61K | Germany | €0.00 | +0.00% | +0.00% | 0.00 |
| 1229 |
Waverley Pharma Inc
V:WAVE |
$540.00K | CA$746.49K | Canada | CA$0.02 | +50.00% | +50.00% | 227.73K |
| 1230 |
CELLECTAR NEW22 DL-00001
F:NV4 |
$451.63K | €386.30K | Germany | €0.25 | +0.00% | +0.00% | 0.00 |
| 1231 |
CERo Therapeutics Holdings, Inc. Common Stock
NASDAQ:CERO |
$451.12K | $451.12K | USA | $0.01 | +0.00% | -15.25% | 11.64 Million |
| 1232 |
Hemogenyx Pharmaceuticals PLC
LSE:HEMO |
$400.85K | GBX3.29 Billion | UK | GBX614.50 | -2.85% | -9.10% | 249.05K |
| 1233 |
ALBERT LABS INTL. CORP.
F:VB50 |
$372.07K | €318.25K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1234 |
Lidds AB
ST:LIDDS |
$361.27K | Skr3.36 Million | Sweden | Skr0.02 | +0.00% | +17.14% | 8.44 Million |
| 1235 |
Vaxil Bio Ltd
V:VXL |
$346.81K | CA$479.43K | Canada | CA$0.18 | +2.94% | -2.78% | 24.19K |
| 1236 |
Qlucore AB (publ)
ST:NOVKAN |
$326.04K | Skr3.03 Million | USA | Skr0.03 | -43.95% | -54.46% | 38.54 Million |
| 1237 |
Protagenic Therapeutics
NASDAQ:PTIX |
$325.84K | $325.84K | USA | $0.18 | +20.00% | -16.67% | 147.17K |
| 1238 |
Biophytis S.A.
PA:ALBPS |
$314.94K | €269.39K | France | €0.01 | -58.17% | -58.17% | 42.16 Million |
| 1239 |
SkinBioTherapeutics PLC
LSE:SBTX |
$307.45K | GBX2.53 Billion | UK | GBX9.75 | +0.00% | +24.20% | 55.90 Million |
| 1240 |
ORUM
KQ:475830 |
$297.29K | ₩438.69 Million | Korea | ₩44600.00 | +17.99% | -6.50% | 2.68 Million |
| 1241 |
Arecor Therapeutics PLC
LSE:AREC |
$280.23K | GBX2.30 Billion | UK | GBX61.00 | -3.94% | -3.94% | 190.33K |
| 1242 |
PCI Biotech Holding ASA
OL:PCIB |
$274.95K | Nkr2.61 Million | Norway | Nkr0.07 | -39.13% | -53.95% | 22.88 Million |
| 1243 |
Virpax Pharmaceuticals Inc
NASDAQ:VRPX |
$273.35K | $273.35K | USA | $0.22 | +0.00% | +0.00% | 157.00 |
| 1244 |
Oxurion NV
BR:OXUR |
$248.85K | €212.86K | Belgium | €0.00 | -14.29% | +0.00% | 18.14 Million |
| 1245 |
ImmuPharma PLC
LSE:IMM |
$218.98K | GBX1.80 Billion | UK | GBX3.58 | -3.24% | -10.50% | 34.51 Million |
| 1246 |
Kiromic Biopharma Inc
NASDAQ:KRBP |
$214.93K | $214.93K | USA | $21.98 | -0.55% | -3.08% | 16.75K |
| 1247 |
IXICO PLC
LSE:IXI |
$213.14K | GBX1.75 Billion | UK | GBX8.00 | -3.03% | -5.88% | 1.75 Million |
| 1248 |
Roquefort Investments PLC
LSE:ROQ |
$184.27K | GBX1.51 Billion | UK | GBX9.25 | +873.68% | +802.44% | 23.80 Million |
| 1249 |
HAVN LIFE SCIENCES INC.
F:5NP0 |
$172.31K | €147.39K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1250 |
Aptamer Group PLC
LSE:APTA |
$155.87K | GBX1.28 Billion | UK | GBX0.48 | +0.00% | +3.26% | 74.38 Million |
| 1251 |
Lipella Pharmaceuticals Inc. Common Stock
NASDAQ:LIPO |
$152.49K | $152.49K | USA | $0.03 | +0.00% | +0.00% | 513.77K |
| 1252 |
QuiaPEG Pharmaceuticals Holding AB
ST:QUIA |
$141.00K | Skr1.31 Million | Sweden | Skr0.00 | -16.67% | -44.44% | 1.38 Billion |
| 1253 |
Fusion Antibodies PLC
LSE:FAB |
$134.83K | GBX1.11 Billion | UK | GBX9.75 | +0.00% | -9.30% | 6.00 Million |
| 1254 |
NANOSPHERE HEA.SCIENCES
F:2CG |
$108.12K | €92.48K | Germany | €0.01 | +0.00% | -35.71% | 0.00 |
| 1255 |
Scandion Oncology A/S
ST:SCOL |
$103.58K | Skr962.52K | Sweden | Skr0.00 | +0.00% | +0.00% | 29.31 Million |
| 1256 |
Lipigon Pharmaceuticals AB
ST:LPGO |
$97.81K | Skr908.90K | Sweden | Skr0.00 | -44.44% | -61.54% | 559.62 Million |
| 1257 |
Cizzle Biotechnology Holdings PLC
LSE:CIZ |
$89.22K | GBX733.32 Million | UK | GBX1.85 | -2.63% | -9.76% | 46.24 Million |
| 1258 |
OptiBiotix Health Plc
LSE:OPTI |
$72.27K | GBX593.98 Million | UK | GBX5.75 | +0.00% | +2.68% | 3.55 Million |
| 1259 |
Vincerx Pharma, Inc. Common Stock
NASDAQ:VINC |
$66.48K | $66.48K | USA | $0.01 | +0.00% | +0.00% | 128.84K |
| 1260 |
Amur Minerals Corporation
LSE:CRTX |
$59.80K | GBX491.49 Million | UK | GBX9.50 | +0.00% | +0.00% | 6.68 Million |
| 1261 |
Nuformix plc
LSE:NFX |
$37.22K | GBX305.91 Million | UK | GBX0.15 | +4.32% | -14.71% | 217.32 Million |
| 1262 |
Futura Medical
LSE:FUM |
$29.57K | GBX243.00 Million | UK | GBX0.42 | +10.29% | +4.50% | 146.08 Million |
| 1263 |
Physiomics Plc
LSE:PYC |
$26.47K | GBX217.54 Million | UK | GBX0.48 | +0.00% | -4.00% | 78.54 Million |
| 1264 |
BSF Enterprise Plc
LSE:BSFA |
$13.28K | GBX109.12 Million | UK | GBX0.85 | +6.25% | +0.00% | 41.56 Million |
| 1265 |
Trevena Inc
NASDAQ:TRVN |
$9.50K | $9.50K | USA | $0.01 | +0.00% | +0.00% | 2.15K |
| 1266 |
Carisma Therapeutics Inc.
NASDAQ:CARM |
$8.37K | $8.37K | USA | $0.00 | +13.64% | -40.48% | 268.14K |
| 1267 |
Windtree Therapeutics Inc
NASDAQ:WINT |
$6.74K | $6.74K | USA | $0.00 | -98.00% | -98.00% | 695.86K |
| 1268 |
CannBioRx Life Sciences Corp
NASDAQ:ATNFW |
$4.02K | $4.02K | USA | $0.43 | -6.52% | +4200.00% | 56.97 Million |
| 1269 |
Aditxt Inc.
NASDAQ:ADTX |
$2.12K | $2.12K | USA | $0.00 | +0.00% | -25.71% | 964.28 Million |
| 1270 |
Effector Therapeutics Inc
NASDAQ:EFTR |
$940.00 | $940.00 | USA | $0.00 | +0.00% | -66.67% | 38.52K |
| 1271 |
Tissue Regenix Group Plc
LSE:TRX |
$628.37 | GBX5.16 Million | UK | GBX0.07 | +0.00% | -99.19% | 22.85 Million |
| 1272 |
Lixte Biotechnology Holdings Inc
NASDAQ:LIXTW |
$219.38 | $219.38 | USA | $0.02 | -0.45% | -68.35% | 1.02 Million |
| 1273 |
NLS Pharmaceutics AG
NASDAQ:NLSPW |
$165.13 | $165.13 | USA | $0.02 | -0.56% | +37.69% | 1.50 Million |
| 1274 |
Seelos Therapeutics, Inc.
NASDAQ:SEELQ |
$58.00 | $58.00 | USA | $0.00 | +0.00% | +0.00% | 0.00 |
| 1275 |
Neovacs S.A.
PA:ALNEV |
$40.11 | €34.31 | France | €0.73 | +2.80% | -9.87% | 194.04K |
| 1276 |
Reviva Pharmaceuticals Holdings Inc
NASDAQ:RVPHW |
$27.42 | $27.42 | USA | $0.00 | -16.67% | -69.07% | 3.22 Million |
| 1277 |
immatics biotechnologies GmbH
NASDAQ:IMTXW |
$5.77 | $5.77 | USA | $0.00 | +0.00% | +0.00% | 39.12K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries